Stockscreener 앱 받기
132.66
0.98%
1.29
Abbott Laboratories 주식(ABT)의 최신 뉴스
What institutional flow reveals about Abbott LaboratoriesRate Cut & Long-Term Capital Growth Strategies - Newser
What MACD and RSI say about Abbott LaboratoriesJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
Abbott Laboratories CEO warns tariffs are here to stay, points to new US investments [Video] - AOL.com
Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com
A Look at Abbott Laboratories’s Valuation Following Strong Medical Device Launches and Regulatory Milestones - simplywall.st
Abbott’s Possible Pokeno Acquisition Might Change the Case for Investing in Abbott Laboratories (ABT) - Yahoo Finance
Is now a turning point for Abbott LaboratoriesJuly 2025 Catalysts & Low Risk Growth Stock Ideas - Newser
Abbott Laboratories stock trend outlook and recovery pathJuly 2025 Summary & Risk Managed Investment Signals - Newser
Does Abbott Laboratories fit your quant trading modelMarket Sentiment Report & Daily Profit Focused Screening - Newser
Ranking Abbott Laboratories among high performing stocks via toolsPortfolio Update Report & Free Risk Controlled Daily Trade Plans - Newser
How to integrate Abbott Laboratories into portfolio analysis toolsJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser
Price action breakdown for Abbott LaboratoriesWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - Newser
Price momentum metrics for Abbott Laboratories explainedJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - Newser
Stock Analysis | Abbott Laboratories OutlookNavigating Mixed Signals in a Volatile Market - AInvest
IoT in Healthcare Market to See Thriving Worldwide | Abbott Laboratories, Philips, Medtronic - openPR.com
Can a trend reversal in Abbott Laboratories lead to recoveryJuly 2025 Trends & Low Risk Profit Maximizing Plans - Newser
St. Jude Medical delivers sales growth for Abbott Labs - Star Tribune
What earnings revisions data tells us about Abbott LaboratoriesJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - Newser
Abbott Laboratories: Is The Growth in Continuous Glucose Monitoring (CGM) & Ketone Monitoring Here To Stay? - Smartkarma
Applying chart zones and confluence areas to Abbott Laboratories2025 Institutional Moves & Weekly High Potential Alerts - Newser
Live market analysis of Abbott Laboratories2025 Price Action Summary & Comprehensive Market Scan Insights - Newser
Abbott Laboratories Severance Pay: Your Rights Explained - Samfiru Tumarkin LLP
Abbott receives expanded approval for Navitor TAVR system - Cardiovascular Business
Does Abbott Laboratories show high probability of reboundBond Market & Entry Point Confirmation Signals - Newser
Is Abbott Laboratories stock poised for growthBuy Signal & Consistent Return Investment Signals - Newser
ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now? - TradingView
How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Abbott gets EU CE Mark for expanded use of Navitor TAVI system - Seeking Alpha
Abbott Laboratories Receives CE Mark for Expanded Indication for Navitor Aortic Valve Implant - MarketScreener
Major Breakthrough: Abbott's Navitor Heart Valve Now Approved for All Surgical Risk Levels in Europe - Stock Titan
Abbott Laboratories stock chart pattern explained2025 Big Picture & Low Risk Entry Point Tips - Newser
What makes Abbott Laboratories stock price move sharplyJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
Formula makers have been hiding the truth — and endangering the tiniest babies | Opinion - The Tennessean
Can machine learning forecast Abbott Laboratories recoveryJuly 2025 Trends & Community Verified Trade Signals - Newser
Abbott wins expanded CE mark for Navitor TAVI system, reports updated TEER guidelines - MassDevice
Tools to assess Abbott Laboratories’s risk profileMarket Growth Summary & Real-Time Sentiment Analysis - Newser
The top Abbott stories of 2025 so far - MassDevice
Genetic Material Market Size, Trends and Top Companies (2025 – 2034 Forecast Period) - GlobeNewswire Inc.
0.24%
0.45%
자본화:
|
볼륨(24시간):